Lin Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lin Li has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
Liu Xiao
Department of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu, P.R. China
36 shared publicationsPing Dong
Department of Nuclear Medicine, West China Hospital, Sichuan University
10 shared publicationsRui Huang
Department of Nuclear Medicine
10 shared publicationsHangyu Xie
Department of Nuclear Medicine
8 shared publications- Huawei Cai
Department of Nuclear Medicine & Laboratory of Clinical Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China
8 shared publications Yuhao Li
Department of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu, people’s republic of China
8 shared publications
Latest Publications
- Open Access
- 1 October 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-8
Non-specific uptake of 68Ga-FAPI PET/CT in the pancreas and its related factor: a retrospective, single-center study
This study aims to analyze the characteristics of non-specific uptake(NSU) of 68Ga-FAPI in the pancreas and explore potential independent factors associated with its presence on 68Ga-FAPI PET/CT images. This retrospective study included 122 patients who underwent 68Ga-FAPI PET/CT examinations for stage and re-stage of abdominal malignant tumor, dividing patients with pancreatic NSU and patients without pancreatic NSU. Patients with clinical evidence of pancreatitis or pancreas tumor were excluded. Univariate and multivariate regression analysis were used to identify factors associated with pancreatic NSU. ROC curve analysis was used to evaluate optimal cut-off for the presence of pancreatic NSU. A total of 122 patients were included in the final analysis, comprising 42 patients with pancreatic NSU and 80 patients without NSU. The SUVmax was 7.94 ± 5.39 and 2.01 ± 0.50 in NSU and non-NSU group respectively on 68Ga-FAPI PET/CT. Univariate and multivariate regression analysis identified independent risk factors associated with pancreatic NSU, including diabetes (OR: 6.894, 95% CI: 1.208–39.331, P = 0.03), hematocrit (OR: 0.858, 95% CI: 0.749–0.983, P = 0.027), and CRP (OR: 1.029, 95% CI: 1.009–1.049, P = 0.005). ROC curve analysis determined the optimal cut-off of 17.85 and 37.5 for CRP and hematocrit in predicting NSU in the pancreas on 68Ga-FAPI PET/CT imaging. Pancreatic diffuse NSU is associated with the presence of diabetes, lower hematocrit levels, and higher CRP levels. These findings may assist clinicians and nuclear medicine physicians in interpreting imaging appearances, helping to avoid misdiagnosis.
- 1 October 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-8
Open AccessNon-specific uptake of 68Ga-FAPI PET/CT in the pancreas and its related factor: a retrospective, single-center study
This study aims to analyze the characteristics of non-specific uptake(NSU) of 68Ga-FAPI in the pancreas and explore potential independent factors associated with its presence on 68Ga-FAPI PET/CT images. This retrospective study included 122 patients who underwent 68Ga-FAPI PET/CT examinations for stage and re-stage of abdominal malignant tumor, dividing patients with pancreatic NSU and patients without pancreatic NSU. Patients with clinical evidence of pancreatitis or pancreas tumor were excluded. Univariate and multivariate regression analysis were used to identify factors associated with pancreatic NSU. ROC curve analysis was used to evaluate optimal cut-off for the presence of pancreatic NSU. A total of 122 patients were included in the final analysis, comprising 42 patients with pancreatic NSU and 80 patients without NSU. The SUVmax was 7.94 ± 5.39 and 2.01 ± 0.50 in NSU and non-NSU group respectively on 68Ga-FAPI PET/CT. Univariate and multivariate regression analysis identified independent risk factors associated with pancreatic NSU, including diabetes (OR: 6.894, 95% CI: 1.208–39.331, P = 0.03), hematocrit (OR: 0.858, 95% CI: 0.749–0.983, P = 0.027), and CRP (OR: 1.029, 95% CI: 1.009–1.049, P = 0.005). ROC curve analysis determined the optimal cut-off of 17.85 and 37.5 for CRP and hematocrit in predicting NSU in the pancreas on 68Ga-FAPI PET/CT imaging. Pancreatic diffuse NSU is associated with the presence of diabetes, lower hematocrit levels, and higher CRP levels. These findings may assist clinicians and nuclear medicine physicians in interpreting imaging appearances, helping to avoid misdiagnosis.
- Open Access
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-6
Value of integrated PET-IVIM MRI in predicting Ki-67 expression in newly diagnosed prostate cancer
Accurate assessment of Ki-67 expression in patients with prostate cancer (PC) is paramount. Therefore, this study aimed to assess the value of integrated Gallium-68(68Ga)-prostate-Specific membrane antigen-11 (PSMA) Positron Emission Tomography/Intravoxel Incoherent Motion Magnetic Resonance Imaging (PET/IVIM MRI) in predicting Ki-67 expression in newly diagnosed PC. A retrospective analysis was conducted on 37 newly diagnosed PC patients who underwent 68Ga-PSMA-11 PET/MR for staging. Maximum Standardized Uptake Value( SUVmax) and IVIM parameters of lesions were quantified. Patients were stratified into low-risk (Ki-67 < 5%) and high-risk groups (Ki-67 > 5%). SUVmax and IVIM parameters were compared between the two groups. Of the 37 patients, 29 were categorized as high risk, while 8 were classified as low risk. The high-risk group exhibited significantly higher SUVmax (21.4 ± 11.3 vs. 11.2 ± 8.5, P = 0.025) and lower Standard apparent diffusion coefficient (ADC) (0.0011 ± 0.00023 vs. 0.0014 ± 0.00039, P = 0.005) compared to the low-risk group. Receiver operating characteristic (ROC) analysis determined optimal cut-off values for predicting high-risk patients as 7.64 for SUVmax (sensitivity: 96.6%, specificity: 59.1%) and 0.0013 for standard ADC (sensitivity: 89.7%, specificity: 52.3%). Integrated assessment of SUVmax and standard ADC using 68Ga-PSMA-11 PET-IVIM MRI may aid in predicting Ki-67 expression, with optimal thresholds of 7.67 for SUVmax and 0.0013 for standard ADC. These findings offer novel insights into evaluating the biological behavior of prostate cancer tumors in patients undergoing PET/MR imaging.
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-6
Open AccessValue of integrated PET-IVIM MRI in predicting Ki-67 expression in newly diagnosed prostate cancer
Accurate assessment of Ki-67 expression in patients with prostate cancer (PC) is paramount. Therefore, this study aimed to assess the value of integrated Gallium-68(68Ga)-prostate-Specific membrane antigen-11 (PSMA) Positron Emission Tomography/Intravoxel Incoherent Motion Magnetic Resonance Imaging (PET/IVIM MRI) in predicting Ki-67 expression in newly diagnosed PC. A retrospective analysis was conducted on 37 newly diagnosed PC patients who underwent 68Ga-PSMA-11 PET/MR for staging. Maximum Standardized Uptake Value( SUVmax) and IVIM parameters of lesions were quantified. Patients were stratified into low-risk (Ki-67 < 5%) and high-risk groups (Ki-67 > 5%). SUVmax and IVIM parameters were compared between the two groups. Of the 37 patients, 29 were categorized as high risk, while 8 were classified as low risk. The high-risk group exhibited significantly higher SUVmax (21.4 ± 11.3 vs. 11.2 ± 8.5, P = 0.025) and lower Standard apparent diffusion coefficient (ADC) (0.0011 ± 0.00023 vs. 0.0014 ± 0.00039, P = 0.005) compared to the low-risk group. Receiver operating characteristic (ROC) analysis determined optimal cut-off values for predicting high-risk patients as 7.64 for SUVmax (sensitivity: 96.6%, specificity: 59.1%) and 0.0013 for standard ADC (sensitivity: 89.7%, specificity: 52.3%). Integrated assessment of SUVmax and standard ADC using 68Ga-PSMA-11 PET-IVIM MRI may aid in predicting Ki-67 expression, with optimal thresholds of 7.67 for SUVmax and 0.0013 for standard ADC. These findings offer novel insights into evaluating the biological behavior of prostate cancer tumors in patients undergoing PET/MR imaging.
- 7 April 2025
18F-FDG PET/CT image of invasive hemangioma in the lumbar vertebra.
In the usual scenario, vertebral hemangiomas do not demonstrate heightened uptake above background on fluorine-18-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) scans. Here we presented a case of a positive 18F-FDG PET/CT result indicating invasive vertebral hemangioma at the L2 vertebra, with atypical CT imaging features of heterogeneous increased density and multiple patchy density shadows. Our case underscores an additional uncommon aspect of invasive vertebral hemangioma imaging, warranting consideration in the differential diagnosis when encountering analogous findings on 18F-FDG PET/CT.
- 7 April 2025
18F-FDG PET/CT image of invasive hemangioma in the lumbar vertebra.
In the usual scenario, vertebral hemangiomas do not demonstrate heightened uptake above background on fluorine-18-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) scans. Here we presented a case of a positive 18F-FDG PET/CT result indicating invasive vertebral hemangioma at the L2 vertebra, with atypical CT imaging features of heterogeneous increased density and multiple patchy density shadows. Our case underscores an additional uncommon aspect of invasive vertebral hemangioma imaging, warranting consideration in the differential diagnosis when encountering analogous findings on 18F-FDG PET/CT.
- 5 March 2025
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 50 (10) , e591-e592
FDG PET/CT Image of Symmetric Tendon Xanthoma
Tendon xanthoma is very rare. We report FDG PET/CT findings of tendon xanthoma in a 33-year-old man. On FDG PET/CT image, it manifested as multiple symmetric nodules with an SUVmax of 9.37, located in the tendons of both elbows, knees and ankles. The final pathology supported a diagnosis of a tendon xanthoma.
- 5 March 2025
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 50 (10) , e591-e592
FDG PET/CT Image of Symmetric Tendon Xanthoma
Tendon xanthoma is very rare. We report FDG PET/CT findings of tendon xanthoma in a 33-year-old man. On FDG PET/CT image, it manifested as multiple symmetric nodules with an SUVmax of 9.37, located in the tendons of both elbows, knees and ankles. The final pathology supported a diagnosis of a tendon xanthoma.
- Open Access
- 28 February 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-10
Blood metabolites reflect the effect of gut microbiota on differentiated thyroid cancer: a Mendelian randomization analysis
Background: Studies have linked gut microbiome and differentiated thyroid cancer (DTC). However, their causal relationships and potential mediating factors have not been well defined. Our study investigated the causal relationships between the gut microbiome, papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC), as well as the mediating effect of potential blood metabolites, using genetic approaches. Methods: Leveraging the summary statistics of gut microbial taxa, blood metabolites, PTC and FTC from the largest genome-wide association studies (GWAS) to date, we applied the bidirectional and mediation Mendelian randomization (MR) design. The multivariable MR approach based on Bayesian model averaging (MR-BMA) was used to prioritize the most likely causal taxa. Furthermore, metabolic pathway analysis was performed via the web-based Metaconflict 4.0. Results: After sensitivity analyses, we identified 4 taxa, 19 blood metabolites, and 5 gut bacterial pathways were causally associated with PTC. Similarly, 3 taxa, 31 blood metabolites, and 3 gut bacterial pathways were found to be causally associated with FTC, with 2 blood metabolites exhibiting bidirectional causal relationships. Metabolic pathway analysis revealed 8 significant pathways in PTC and FTC. MR-BMA analysis pinpointed species Bifidobacterium longum as the primary causal taxon for PTC and genus Bacteroides for FTC. The mediation MR analysis showed that sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) and 2-hydroxysebacate mediated the causal effects of specific gut microbiota on PTC and FTC, respectively. Conclusion: The study suggested a causal relationship between several gut microbial taxa and DTC, and that specific blood metabolites might mediate this relationship.
- 28 February 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-10
Open AccessBlood metabolites reflect the effect of gut microbiota on differentiated thyroid cancer: a Mendelian randomization analysis
Background: Studies have linked gut microbiome and differentiated thyroid cancer (DTC). However, their causal relationships and potential mediating factors have not been well defined. Our study investigated the causal relationships between the gut microbiome, papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC), as well as the mediating effect of potential blood metabolites, using genetic approaches. Methods: Leveraging the summary statistics of gut microbial taxa, blood metabolites, PTC and FTC from the largest genome-wide association studies (GWAS) to date, we applied the bidirectional and mediation Mendelian randomization (MR) design. The multivariable MR approach based on Bayesian model averaging (MR-BMA) was used to prioritize the most likely causal taxa. Furthermore, metabolic pathway analysis was performed via the web-based Metaconflict 4.0. Results: After sensitivity analyses, we identified 4 taxa, 19 blood metabolites, and 5 gut bacterial pathways were causally associated with PTC. Similarly, 3 taxa, 31 blood metabolites, and 3 gut bacterial pathways were found to be causally associated with FTC, with 2 blood metabolites exhibiting bidirectional causal relationships. Metabolic pathway analysis revealed 8 significant pathways in PTC and FTC. MR-BMA analysis pinpointed species Bifidobacterium longum as the primary causal taxon for PTC and genus Bacteroides for FTC. The mediation MR analysis showed that sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) and 2-hydroxysebacate mediated the causal effects of specific gut microbiota on PTC and FTC, respectively. Conclusion: The study suggested a causal relationship between several gut microbial taxa and DTC, and that specific blood metabolites might mediate this relationship.
- 6 January 2025
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 50 (6) , e368-e369
Uncommon Breast Metastasis From Rectal Carcinoma Clearly Revealed on 68Ga-FAPI-04 PET/CT
Breast metastasis from rectal carcinoma is very rare. We report a case of imaging findings of breast metastasis in a 31-year-old woman who underwent laparoscopic radical tumor resection 8 months ago. 68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT showed 4 small breast nodules with intense 68Ga-FAPI uptake (SUVmax, 9.22) but slight 18F-FDG uptake (SUVmax, 1.95). Needle biopsy supported a diagnosis of metastasis from rectal adenocarcinoma.
- 6 January 2025
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 50 (6) , e368-e369
Uncommon Breast Metastasis From Rectal Carcinoma Clearly Revealed on 68Ga-FAPI-04 PET/CT
Breast metastasis from rectal carcinoma is very rare. We report a case of imaging findings of breast metastasis in a 31-year-old woman who underwent laparoscopic radical tumor resection 8 months ago. 68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT showed 4 small breast nodules with intense 68Ga-FAPI uptake (SUVmax, 9.22) but slight 18F-FDG uptake (SUVmax, 1.95). Needle biopsy supported a diagnosis of metastasis from rectal adenocarcinoma.
- 1 December 2024
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 49 (12) , e726-e727
FDG PET/CT Image of Extragastrointestinal Stromal Tumor in the Posterior Mediastinum
Extragastrointestinal stromal tumor (EGIST) in the posterior mediastinum is very rare. Herein, we report FDG PET/CT findings of posterior mediastinum EGIST in a 77-year-old man. On FDG PET/CT, it manifested as a solitary posterior mediastinum mass with heterogeneous necrosis and intense FDG uptake. The final pathology supported a diagnosis of EGIST. This case hints us when we encounter a soft tissue mass with intense FDG uptake in the posterior mediastinum; EGIST should be regarded as a differential diagnosis.
- 1 December 2024
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 49 (12) , e726-e727
FDG PET/CT Image of Extragastrointestinal Stromal Tumor in the Posterior Mediastinum
Extragastrointestinal stromal tumor (EGIST) in the posterior mediastinum is very rare. Herein, we report FDG PET/CT findings of posterior mediastinum EGIST in a 77-year-old man. On FDG PET/CT, it manifested as a solitary posterior mediastinum mass with heterogeneous necrosis and intense FDG uptake. The final pathology supported a diagnosis of EGIST. This case hints us when we encounter a soft tissue mass with intense FDG uptake in the posterior mediastinum; EGIST should be regarded as a differential diagnosis.
- 1 May 2024
- Vol. 27 (2) , 159-160
18F-FDG PET/CT image of NK/T cell lymphoma in the sacroiliac joint
NK/T cell lymphoma in the sacroiliac joint is very rare. We report uorine-18-uorodeoxyglucose (F-18-FDG) positron emission tomography/computed tomography (PET/CT) ndings of NK/T cell lymphoma in the sacroiliac joint in a 48-year-old man. On F-18-FDGPET/CTimage, it manifested a soft tissue mass with adjacent bone destruction in the sacroiliac joint, which had intense F-18-FDGuptake. The nal pathology supported a diagnosis of NK/T cell lymphoma. Our case added the knowledge of another rare site of NK/T cell lymphoma, which should be regarded as a dierential diagnosis for sac-roiliac joint mass with intense F-18-FDGuptake
- 1 May 2024
- Vol. 27 (2) , 159-160
18F-FDG PET/CT image of NK/T cell lymphoma in the sacroiliac joint
NK/T cell lymphoma in the sacroiliac joint is very rare. We report uorine-18-uorodeoxyglucose (F-18-FDG) positron emission tomography/computed tomography (PET/CT) ndings of NK/T cell lymphoma in the sacroiliac joint in a 48-year-old man. On F-18-FDGPET/CTimage, it manifested a soft tissue mass with adjacent bone destruction in the sacroiliac joint, which had intense F-18-FDGuptake. The nal pathology supported a diagnosis of NK/T cell lymphoma. Our case added the knowledge of another rare site of NK/T cell lymphoma, which should be regarded as a dierential diagnosis for sac-roiliac joint mass with intense F-18-FDGuptake
- 22 February 2024
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 49 (4) , 366-368
Struma Ovarii With Extensive Peritoneal Implants Metastasis Revealed by 99mTcO4 SPECT/CT
Struma ovarii is a rare form of ovarian teratoma composed entirely or mainly of mature thyroid tissue. A 55-year-old woman with persistent hypogastric pain for 4 months was admitted to our hospital. She had undergone resection of struma ovarii 4 years ago. Contrast-enhanced CT shows multiple significantly enhanced nodules scattered in the abdominopelvic cavity. Pathological examination of the nodule in the left pararenal region demonstrated thyroid-like follicular epithelium. Herein, we present the 99mTcO4 whole-body scintigraphy SPECT/CT findings of a case of struma ovarii with extensive peritoneal implants metastasis. Then, she was treated with total thyroidectomy and 131I therapy.
- 22 February 2024
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 49 (4) , 366-368
Struma Ovarii With Extensive Peritoneal Implants Metastasis Revealed by 99mTcO4 SPECT/CT
Struma ovarii is a rare form of ovarian teratoma composed entirely or mainly of mature thyroid tissue. A 55-year-old woman with persistent hypogastric pain for 4 months was admitted to our hospital. She had undergone resection of struma ovarii 4 years ago. Contrast-enhanced CT shows multiple significantly enhanced nodules scattered in the abdominopelvic cavity. Pathological examination of the nodule in the left pararenal region demonstrated thyroid-like follicular epithelium. Herein, we present the 99mTcO4 whole-body scintigraphy SPECT/CT findings of a case of struma ovarii with extensive peritoneal implants metastasis. Then, she was treated with total thyroidectomy and 131I therapy.
- 22 December 2023
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 49 (2) , 201-203
18F-FDG PET/CT Imaging of Isolated Myeloid Sarcoma in the Right Humerus
Myeloid sarcoma is a neoplastic mass formed by the infiltration of primitive or immature myeloid cells into organs and tissues outside the bone marrow. It may occur before, at the same time, or manifest as the recurrence of acute myeloid leukemia, myelodysplastic syndromes, and chronic myeloproliferative syndromes. It may involve any organ or tissue, including skin, soft tissue, lymph nodes, and gastrointestinal tract and bone. Isolated humerus involvement is extremely rare. Herein, we present the FDG PET/CT findings of a rare case of isolate myeloid sarcoma in the right humerus, which showed only increased bone density with moderate FDG uptake.
- 22 December 2023
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 49 (2) , 201-203
18F-FDG PET/CT Imaging of Isolated Myeloid Sarcoma in the Right Humerus
Myeloid sarcoma is a neoplastic mass formed by the infiltration of primitive or immature myeloid cells into organs and tissues outside the bone marrow. It may occur before, at the same time, or manifest as the recurrence of acute myeloid leukemia, myelodysplastic syndromes, and chronic myeloproliferative syndromes. It may involve any organ or tissue, including skin, soft tissue, lymph nodes, and gastrointestinal tract and bone. Isolated humerus involvement is extremely rare. Herein, we present the FDG PET/CT findings of a rare case of isolate myeloid sarcoma in the right humerus, which showed only increased bone density with moderate FDG uptake.